Orion Infusion plans to raise its paid-up capital from Tk 203.60 million to Tk 305.40 million by issuing one new share for every two existing shares. Investors can purchase one new share at Tk 20 for every two they currently hold, with the company set to collect Tk 203.60 million by selling 10.18 million shares at Tk 20 each.
The funds raised will be used to repay bank loans and support the company’s expansion, modernization, rehabilitation, and balancing efforts. The proposal requires approval from shareholders and the Bangladesh Securities and Exchange Commission (BSEC).
The company also reported a 1.9% YoY decline in earnings for FY23, amounting to Tk 41.9 million, and recommended a 10% cash dividend for the year. Orion Infusion’s stock is currently trading at Tk 332.90, having seen significant fluctuations in the past year. Its net asset value per share rose from Tk 14.22 in FY22 to Tk 14.32 in FY23, with the net cash flow per share also increasing to Tk 2.98 in FY23 from Tk 2.23 in the previous year.